1-5 of 5
Kateřina Machová Poláková, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

"Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

Susanne Saussele, MD, Johan Richter, MD PhD, Joelle Guilhot, PhD, Henrik Hjorth-Hansen, MD, Antonio Medina de Almeida, MD PhD, Jeroen J. W. M. Janssen, MD, Jiri Mayer, Prof, MD SCs, Perttu Koskenvesa, MD, Panayiotis Panayiotidis, MD PhD, Ulla Olsson-Strömberg, MD PhD, Juan Luis Steegmann, MD PhD, Hanne Vestergaard, MD, Hans Ehrencrona, MD PhD, Veli Kairisto, Kateřina Machová Poláková, PhD, Martin Müller, MD, Satu Mustjoki, MDPhD, Marc G. Berger, MD PhD, Philippe Rousselot, Martine Escoffre-Barbe, MD, Gabriel Etienne, MD PhD, Jolanta Dengler, MD, Françoise Rigal-Huguet, MD, Nikolas von Bubnoff, MD, Hana Klamova, MD, Edgar Faber, MD, François Guilhot, MD, Kourosh Lotfi, MD, Delphine Rea, MD, Tim H. Brümmendorf, MD, Gorgine de Greef, MD, Leif Stenke, MD, Franck Emmanuel Nicolini, MD PhD, Laurence Legros, MD PhD, Andreas Burchert, MD, Jaroslava Voglová, MD, Aude Charbonnier, MD, Emmanuel Gyan, MDPhD, Maria-Elisabeth Goebeler, MD, Peter E. Westerweel, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 313.
https://doi.org/10.1182/blood.V130.Suppl_1.313.313
Published: 2017
Journal Articles

The Bone Marrow Niche Uses Mir-300 As a Biological Rheostat to Selectively Control Stem Cell-Driven Malignant Hematopoiesis and Innate Anti-Cancer Immunity

Giovannino Silvestri, PhD, Lorenzo Stramucci, PhD, Justin Ellis, Jason Harb, PhD, Paolo Neviani, PhD, Bin Zhang, PhD, Klara Srutova, PhD, Carlo Gambacorti-Passerini, MD, Gabriel Pineda, PhD, Catriona Jamieson, MD PhD, Bruno Calabretta, MD PhD, Fabio Stagno, MD PhD, Paolo Vigneri, MD PhD, G. Nteliopoulos, Philippa May, Alistair Reid, BSc, PhD, Ramiro Garzon, MD, Denis-Claude Roy, MD, Martin Guimond, PhD, Peter Hokland, MD, Michael W. Deininger, MD PhD, Garrett Fitzgerald, MD, Chris Harman, MD, Francesco Dazzi, PhD, Dragana Milojkovic, MBBS, PhD, Jane F. Apperley, FRCP, FRCPath, MD MBChB, Guido Marcucci, MD, Jianfei Qi, PhD, Kateřina Machová Poláková, PhD, Xiaoxuan Fan, PhD, Maria R. Baer, MD, Rossana Trotta, PhD, Danilo Perrotti, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 45.
https://doi.org/10.1182/blood.V130.Suppl_1.45.45
Published: 2017
Journal Articles

In Chronic Myeloid Leukemia Patients on 2nd-Line Tyrosine Kinase Inhibitor Therapy, Deep Sequencing at the Time of Warning May Allow Sensitive Detection of Emerging BCR-ABL1 Mutants

Simona Soverini, PhD, Caterina De Benedittis, Luca Zazzeroni, Katerina Machova Polakova, PhD, Fausto Castagnetti, MD PhD, Gabriele Gugliotta, MD, Maria Teresa Bochicchio, Ilaria Iacobucci, PhD, Marzia Salvucci, MD, Monica Crugnola, MD, Gianni Binotto, MD, Massimiliano Bonifacio, Giovanna Leonardi, MD, Alessandra Iurlo, MD, Giorgina Specchia, MD, Domenico Russo, MD PhD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Gianantonio Rosti, MD, Michele Cavo, MD, Michele Baccarani, Giovanni Martinelli
Journal: Blood
Blood (2014) 124 (21): 815.
https://doi.org/10.1182/blood.V124.21.815.815
Published: 2014
Journal Articles

Interim Analysis of a Pan European Stop Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI study

Francois-Xavier Mahon, MD PhD, Johan Richter, MD PhD, Joelle Guilhot, PhD, Martin C Muller, MD, Christian Dietz, PhD, Kimmo Porkka, MD PhD, Henrik Hjorth-Hansen, MD PhD, Franz Gruber, MD, Panos Panagoitidis, MD, Gert J Ossenkoppele, MD PhD, Jiri Mayer, Prof., MD PhD, Antonio Almeida, MD PhD, Katerina Machova Polakova, PhD, Hans Ehrencrona, MD, Veli Kairisto, MD PhD, Marc G Berger, MD PhD, Ulla Olsson stromberg, MD, Satu Mustjoki, MDPhD, Andreas Hochhaus, MD, Markus Pfirrmann, PhD, Susanne Saussele, MD
Journal: Blood
Blood (2014) 124 (21): 151.
https://doi.org/10.1182/blood.V124.21.151.151
Published: 2014
Journal Articles

Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe

Thomas Ernst, MD, Feng Lin, PhD, Helen E White, PhD, Paul La Rosée, MD, Thomas Lion, MD, PhD, Gerlinde Mitterbauer-Hohendanner, MD, Peter Vandenberghe, MD, PhD, Renata Zadro, MD, PhD, Katerina Machova Polakova, PhD, Radek Plachy, PhD, Charlotte Guldborg Nyvold, M.Sci., Ph.D., Tuija Lundán, PhD, Jean-Michel Cayuela, PhD, Thoralf Lange, MD, Martin C. Müller, Katerina Zoi, MD, PhD, Hajnalka Andrikovics, MD, PhD, Tali Tohami, MD, PhD, Fabrizio Pane, MD, Simona Soverini, Francesca Arruga, PhD, Lene Eggen, PhD, Tomasz Sacha, MD, Joana Diamond, MD, PhD, Rodica Talmaci, MD, PhD, Tadej Pajic, MD, PhD, Dolors Colomer, MD, PhD, Monica Hermanson, PhD, Elisabeth Oppliger Leibundgut, PhD, Peter J. M. Valk, PhD, Ugur Ozbek, MD, PhD, Gareth Gerrard, PhD, Giuseppe Saglio, MD, PhD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 894.
https://doi.org/10.1182/blood.V116.21.894.894
Published: 2010